Jeff Ajer
2019
Compensation breakdown
| Non-Equity Incentive Plan | $561,600 |
|---|---|
| Option Awards | $867,181 |
| Salary | $580,192 |
| Stock Awards | $4,303,656 |
| Other | $31,693 |
| Total | $6,344,322 |
Ajer received $4.3M in stock awards, accounting for 68% of the total pay in 2019.
Ajer also received $561.6K in non-equity incentive plan, $867.2K in option awards, $580.2K in salary and $31.7K in other compensation.
Rankings
In 2019, Jeff Ajer's compensation ranked 1,576th out of 13,971 executives tracked by ExecPay. In other words, Ajer earned more than 88.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,576 out of 13,971 | 89th |
Division Manufacturing | 568 out of 5,701 | 90th |
Major group Chemicals And Allied Products | 169 out of 2,200 | 92nd |
Industry group Drugs | 135 out of 1,886 | 93rd |
Industry Pharmaceutical Preparations | 102 out of 1,398 | 93rd |
Pay ratio
| Jeff Ajer's Pay | $6,344,322 |
|---|---|
| Median Employee's Pay | $190,917 |
| Pay Ratio | 33to 1 |
In 2019, the annual total compensation of Jeff Ajer was $6,344,322.
The annual total compensation of the median employee at BioMarin Pharmaceutical was $190,917.
The ratio of Jeff Ajer's pay to the pay of median employee was therefore 33 to one.
Ajer's colleagues
We found five more compensation records of executives who worked with Jeff Ajer at BioMarin Pharmaceutical in 2019.
2019
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2019
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
2019
Robert Baffi
BioMarin Pharmaceutical
President, Global Manufacturing amp; Technical Operations
2019
Daniel Spiegelman
BioMarin Pharmaceutical
Chief Financial Officer
2019
Brian Mueller
BioMarin Pharmaceutical
Chief Financial Officer
News
April 12, 2022
April 13, 2021
April 14, 2020
April 23, 2019